Built for Oxford's businesses

Oxford has real strength in life sciences, publishing and research spinouts, and startups here don't need a generalist down the road — they need specialists who answer quickly and price fairly. Because we work online, you get exactly that, plus a nudge towards the right local support: OxLEP Business is a good first stop for grants and advice, and our Swoop-powered funding portal searches 1,000+ lenders and grant schemes on top.

What matters first for an Oxford research spinout?

Oxford's life-sciences and research spinouts share a pattern: years of spending before any revenue, funded by grants, angel money and institutional stakes. Three things therefore matter very early. Who owns the intellectual property, and on what licence terms, largely decides what the company is worth. R&D relief is usually the largest single cash item in the early years, and claims now need an additional information form filed before the corporation tax return. And EMI share options are how a pre-revenue company competes for people it cannot yet pay properly — worth doing properly, with an agreed valuation and the scheme registered on time. Publishing businesses here more often ask about royalty accounting and the VAT treatment of digital publications.